SMS Lifesciences India Limited

Web: smslife.in NSE: SMSLIFE BSE: 540679 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

1393 39(3%)

Volume

0k as on 24, Jun

Open

High

Low

1,354

VWAP

1,383

52 Week High

1,680

52 Week Low

960

Viand Research Rating

Quality Score

27/100

Growth Score

49/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

421

No. of Shares

0.3

P/E

17.03

P/B

2.1

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.32

ROCE

Profit Growth

Listing Date

17-Aug-17

Promoter Holding

72.1%

FII Holding

DII Holding

0.3%

Price Chart

Price Performance

1 Week3%

1 Month17%

3 Months8%

6 Months8%

1 Year8%

YTD8%

Moving Average

5 Day SMA1,405

10 Day SMA1,405

20 Day SMA1,425

30 Day SMA1,487

50 Day SMA1,468

61 Day SMA1,432

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,466	1,391	1,445	1,469
Resistance 2	1,445	1,386	1,424	1,447
Resistance 1	1,411	1,381	1,411	1,414
Pivot Point	1,390	1,376	1,390	1,392
Support 1	1,356	1,371	1,369	1,359
Support 2	1,335	1,366	1,356	1,337
Support 3	1,301	1,361	1,335	1,304

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.31) 72.10%	(0.41) 71.79%	(0.01) 71.40%	(0.01) 71.40%	(0.01) 71.40%	(0.01) 71.40%	(0.01) 71.40%	(0.21) 71.40%	(0.51) 71.19%	(0.41) 70.68%	(0.01) 70.32%	(0.01) 70.32%	(0.01) 70.32%	(0.51) 70.32%	(0.01) 69.85%	(0.91) 69.85%	(1.31) 68.96%	(0.01) 67.69%	(0.01) 67.74%
FIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.03%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.02%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(0.01) 0.07%	(0.01) 0.04%
DIIs	(0.01) 0.30%	(0.31) 0.29%	(0.01) 0.03%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	27.59%	27.91%	28.57%	28.56%	28.60%	28.59%	28.57%	28.59%	28.81%	29.31%	29.68%	29.68%	29.67%	29.69%	30.14%	30.15%	31.04%	32.23%	32.21%
No. of Shareholders	6,937	7,125	7,521	7,412	7,479	7,626	7,849	7,861	8,116	8,233	8,443	8,475	8,349	8,593	8,799	8,939	8,841	8,843	9,580

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	75.14	94.78	81.37	82.5	89.11	84.6	78.46	92.55	89.99	72.05	69.26	74.65	63.73	88.29	81.26	82.28	95.66	91.06	86.75	76.27
Sales Growth % (YoY)	-15.7%	12%	3.7%	-10.9%	-1%	17.4%	13.3%	24%	41.2%	-18.4%	-14.8%	-9.3%	-33.4%	-3%	-6.3%	7.9%	15.9%	36.8%	40.5%	39.3%
Sales Growth % (QoQ)	-20.7%	16.5%	-1.4%	-7.4%	5.3%	7.8%	-15.2%	2.8%	24.9%	4%	-7.2%	17.1%	-27.8%	8.7%	-1.2%	-14%	5.1%	5%	13.7%	-
Expenses	70.98	80.73	67.79	70.79	81.69	71.85	69.89	76.27	78.63	62.75	61.33	72.11	61.45	78.92	72.99	73.79	89.23	82.59	77.13	68.06
Operating Profit	4.16	14.05	13.58	11.71	7.42	12.75	8.57	16.28	11.36	9.3	7.93	2.54	2.28	9.37	8.27	8.49	6.43	8.47	9.62	8.21
OPM %	5.54	14.82	16.69	14.19	8.33	15.07	10.92	17.59	12.62	12.91	11.45	3.4	3.58	10.61	10.18	10.32	6.72	9.3	11.09	10.76
Other Income	2.01	0.18	0.42	1	2.34	0.06	2.04	0.44	2.36	0.58	0.27	0.61	4.81	0.49	0.15	0.31	6.64	0.03	8.44	0.07
Interest	1.42	1.54	1.62	1.87	2.03	2.14	2.14	2.4	2.84	2.34	2.81	2.18	1.8	1.67	1.68	1.64	1.75	1.49	1.82	1.12
Depreciation	3.85	3.91	3.89	3.82	3.8	3.76	3.76	3.68	3.78	3.73	3.73	3.7	2.92	2.63	2.64	2.59	2.58	2.61	2.69	2.13
Profit before tax	0.9	8.78	8.49	7.02	3.93	6.91	4.71	10.64	7.1	3.81	1.66	-2.73	2.37	5.56	4.1	4.57	8.74	4.4	13.55	5.03
Tax %	62.22	24.26	24.38	37.61	11.45	29.81	29.72	33.27	8.73	-8.14	126.51	40.29	10.55	31.29	23.66	49.23	7.67	46.82	24.28	27.83
Net Profit	0.35	6.65	6.42	4.39	3.48	4.86	3.3	7.1	6.47	4.12	-0.44	-3.83	2.11	3.82	3.12	2.32	8.08	2.33	10.25	3.63
Net Profit Growth % (QoQ)	-94.7%	3.6%	46.2%	26.1%	-28.4%	47.3%	-53.5%	9.7%	57%	1036.4%	88.5%	-281.5%	-44.8%	22.4%	34.5%	-71.3%	246.8%	-77.3%	182.4%	-
Net Profit Growth % (YoY)	-89.9%	36.8%	94.5%	-38.2%	-46.2%	18%	850%	285.4%	206.6%	7.9%	-114.1%	-265.1%	-73.9%	63.9%	-69.6%	-36.1%	-	-	-	-
TTM Net Profit	17.81	20.94	19.15	16.03	18.74	21.73	20.99	17.25	6.32	1.96	1.66	5.22	11.37	17.34	15.85	22.98	24.29	16.21	13.88	0
EPS in Rs	1.46	21.9	20.18	13.76	9.82	18.09	15.45	23.15	19.52	14.22	2.25	-5.95	5.66	13.2	9.1	9.96	26.79	7.71	33.9	12.01

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Sales	334	345	306	316	350	266	261	378
Sales Growth %	-3.2%	12.7%	-3%	-9.9%	31.8%	1.8%	-31%	-
Expenses	289	300	275	287	316	235	235	343
Operating Profit	45	45	31	29	35	30	25	35
OPM %	13	13	10	9	10	11	10	9
Other Income	2	5	4	5	14	2	2	2
Interest	6	9	10	7	6	5	5	6
Depreciation	15	15	15	11	10	8	8	6
Profit before tax	25	26	10	17	33	20	15	25
Tax %	29	28	36	31	23	31	31	30
Net Profit	18	19	6	11	25	14	10	18
Net Profit Growth %	-5.3%	216.7%	-45.5%	-56%	78.6%	40%	-44.4%	-
EPS in Rs	57.26	66.52	30.07	37.91	83.75	44.85	33.67	59.04
Dividend Payout %	3	2	5	4	2	3	0	3

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash from Operating Activity	37	34	24	15	-11	35	15	30
Cash from Investing Activity	-58	-15	-18	-31	-7	-26	-27	-44
Cash from Financing Activity	21	-19	-7	17	11	-3	12	15
Net Cash Flow	1	0	-1	0	-8	6	0	1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Equity Capital	3	3	3	3	3	3	3	3	3	3
Reserves	211	203	194	185	174	166	149	126	113	103
Borrowings	111	70	86	92	101	100	80	65	65	47
Other Liabilities	130	118	107	111	114	126	125	108	72	116
Total Liabilities	454	394	390	391	391	395	357	302	253	270
Fixed Assets	268	226	232	217	223	228	142	130	124	118
CWIP	10	9	0	13	6	1	51	38	16	3
Investments	0	0	0	0	0	0	0	0	0	0
Other Assets	176	159	158	161	162	166	164	134	113	148
Total Assets	454	394	390	391	391	395	357	302	253	270

Delivery

Daily Market Cap

No records found.

Stock Checklist

Price is above from 52 week high low average: 20%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: YES

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView